From the publishers of JADPRO

MPN Resource Center

Advertisement

Developing strategies to reduce the duration of therapy for patients with myeloproliferative neoplasms

This review highlights myeloproliferative neoplasm treatment approaches, currently available and in development, that reduce or potentially eliminate minimal residual disease and allow for drug holidays or potential cures.

Expert Review of Hematology
Advertisement
News & Literature Highlights
Advertisement
Advertisement